News

Big data
21 June 2017
Big data analytics will certainly play a key role in the biology of the not-too-distant future. Clearly, it’s time we dedicated an issue of VIBnews to the topic.
Goal of the VIB Bioinformatics Core: Empowering our people to embrace new big data technologies in their research
21 June 2017
Research data generated by our VIB colleagues involves complex information which requires specialized data applications. More and more scientists are combining this complexity with large volumes at the same time. The result is big data.
ELIXIR: an international brew for smarter big data management and beyond
21 June 2017
In our labs and beyond, massive and ever-increasing amounts of data are being generated. The hyper-fast evolution of big data has pushed life science professionals to look at the issue – and possible solutions – on a larger scale.
Big data in life sciences: hype or hope?
21 June 2017
In life sciences big data technology is helping us cope with a seemingly endless tsunami of biological information. And considering the rapid pace of progress in our sector, we’re just seeing the tip of the iceberg.
VIB groups and big data
21 June 2017
A diagnostic test for ALS
19 June 2017
Researchers at VIB, KU Leuven, and UZ Leuven, in collaboration with researchers at the University of Jena, have demonstrated that measuring neurofilaments provides reliable confirmation of an ALS diagnosis.
Researchers gain new insights into the formation of non-pathological amyloids
19 June 2017
The team of Han Remaut and the lab of Yves Dufrêne at UCL Louvain-La-Neuve collaborated on a study of functional amyloids –protein aggregates with typical amyloid structure that do not lead to disease but rather serve a dedicated biological function.
Aphea.Bio aims at leading position in next generation agricultural biologicals
16 June 2017
VIB, Ghent University and KU Leuven have launched a new spin-off: Aphea.Bio. This new company will develop sustainable agricultural products based on natural microorganisms to increase crop yields and to protect them against specific fungal diseases.
International recognition for Peter Carmeliet (VIB - KU Leuven)
8 June 2017
Peter Carmeliet of VIB-KU Leuven Center for Cancer Biology was appointed as an international member of the Royal Netherlands Academy of Sciences (KNAW). It is very exceptional that foreign researchers are allowed to join this network.
New Centre for Bioassay Development and Screening (C-BIOS) launched to support early-stage drug/agro discovery
2 June 2017
High-content analysis implies multi-parameter imaging of (sub)populations of cells, single cells and subcellular events that can be applied in a set-up compatible with high-throughput screening and automation.
Scientists give tumor-fighting cells a boost in battling bone marrow cancer
1 June 2017
Researchers led by Prof. Dirk Elewaut and the team of Prof. Vanderkerken and Prof. Menu at the Hematology and Immunology lab of the VUB uncovered a new way to enhance the function of a specific type of immune cell that destroys tumors in multiple myeloma
Researchers discover mechanism behind rapid smell source localization
22 May 2017
Scientists at NERF have provided fundamental insights into mechanism of smell localization. This marks an important step in unraveling the entire neural odor localization mechanism, which is highly valuable to the study of memory diseases.
Wim Versées receives Michael J. Fox Foundation grant for investigating Parkinson’s disease-associated protein
20 May 2017
Wim Versées, staff scientists at the VIB-VUB Center for Structural Biology, received a Michael J. Fox Foundation grant. The foundation provides funding for translational and clinical research supporting Parkinson’s-related breakthroughs.
Tau prevents synaptic transmission at early stage of neurodegeneration
19 May 2017
Prof. Patrik Verstreken’s research team (VIB-KU Leuven) has now discovered how tau disrupts the functioning of nerve cells, even before it starts forming tangles. They immediately suggest a way to intervene in this process.
Helena Biosciences to develop automated blood test for chronic liver disease based on VIB and Ghent University research
16 May 2017
Helena Biosciences announced today that it is commercialising a new blood test for Chronic Liver Disease (CLD) in cooperation with the Ghent University branch of VIB – the life sciences research institute of Flanders, Belgium.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 Next»

Get news updates:

Email updates
Follow us on Twitter
Like us on Facebook
RSS